Australia - Inggris - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48170 - gelatin haemostatic agent - following application of the sponge to the surface of the defect or insertion into the surgically created void, the sponge results in rapid haemostasis by concentrating blood platelets and coagulating factors released by surgically/trauma-induced venous or diffuse oozing haemorrhage within the gelatin matrix. the shape and size of the defect determines the sponge configuration most suited to the operative site. an aid to providing haemostasis and obliterating dead space created by the extraction of teeth, root amputations and removal of cysts, tumours and impacted teeth.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48170 - gelatin haemostatic agent - following application of sponge to surface of defect or insertion into the surgically created void, the sponge results in rapid haemostasis by concentrating blood platelets and coagulating factors released by surgically/trauma-induced venous or diffuse oozing haemorrhage within the gelatin matrix. to achieve local haemostasis by tamponade effect; to support and separate tissues to prevent adhesions, e.g.keep the fascia or perichondrium in place following tympanoplasty.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48170 - gelatin haemostatic agent - following delivery of the sponge into the vessel to be occluded, the sponge results in temporary embolisation by concentrating blood platelets and coagulating factors within the gelatin matrix. the shape and size of the vessel determines the sponge configuration most suited to the operative site. to achieve temporary arterial embolisation.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48170 - gelatin haemostatic agent - following application of the sponge to the surface of the defect or insertion into the surgically created void, the sponge results in rapid haemostasis by concentrating blood platelets and coagulating factors released by surgically/trauma-induced venous or diffuse oozing haemorrhage within the gelatin matrix. the shape and size of the defect determines the sponge configuration most suited to the operative site. to achieve rapid haemostasis by tamponade effect.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd - 48170 - gelatin haemostatic agent - a sterile, absorbable porcine gelatin flowable matrix intended for haemostatic use by applying to a bleeding surface. the matrix is supplied pre-filled in a syringe and is mixed with sterile saline, prior to use, using the enclosed accessories (a sterile empty syringe and a liquid transfer cup). after mixing, an applicator tip is attached to the syringe for delivery of the product onto a bleeding site. intended for surgical procedures (except ophthalmic) for haemostasis, when control of capillary, venous and arteriolar procedures is ineffective or impractical

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - succinylated gelatine (= modified fluid gelatine); sodium chloride; sodium acetate trihydrate ; potassium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate - solution for infusion - 4 percent - blood substitutes and plasma protein fractions; gelatin agents

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - succinylated gelatine (= modified fluid gelatine); sodium chloride; sodium hydroxide - solution for infusion - 40 milligram(s)/millilitre - blood substitutes and plasma protein fractions; gelatin agents

Malta - Inggris - Medicines Authority

b braun melsungen ag carl-braun-strasse 1, d34212 melsungen, germany - calcium chloride, dihydrate, gelatin, potassium chloride, magnesium chloride, hexahydrate, sodium acetate, trihydrate, sodium chloride - solution for infusion - calcium chloride dihydrate 0.15 g/l gelatin 40 g/l potassium chloride 0.3 g/l magnesium chloride hexahydrate 0.2 g/l sodium acetate trihydrate 3.27 g/l sodium chloride 5.55 g/l - blood substitutes and perfusion solutions

Malta - Inggris - Medicines Authority

jv healthcare limited - gelatin, sodium, chloride - solution for infusion - gelatin 40 gram(s) ; sodium 154 millimole(s) ; chloride 120 millimole(s) - blood substitutes and perfusion solutions

Malta - Inggris - Medicines Authority

b braun melsungen ag carl-braun-strasse 1, d34212 melsungen, germany - gelatin, sodium chloride, sodium hydroxide - solution for infusion - gelatin 40 g/l sodium chloride 7.01 g/l sodium hydroxide 1.36 g/l - blood substitutes and perfusion solutions